A different study also showed that PTEN and ATM are synthetic lethal partners in breast cancer cells and demonstrated that the sensitivity of PTEN-deficient breast cancer cells to cisplatin was increased with ATM inhibitor KU-60019.163. Here, PTEN is linked to breast carcinoma.